Nasdaq: CBIO
Crescent Biopharma insiders
The officers, directors and 10% owners of Crescent Biopharma, Inc. who hold the most stock, valued at the live CBIO price.
$12.91
CBIO today +$510K (+4.11%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their CBIO stock
- $6.3M
- Market value
- $539M
- Held by ranked insiders
- 1.17%
Insiders by value of CBIO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Joshua T. Brumm | Chief Executive Officer | 271,765 | $3.5M | 0.65% | 7600th |
| 2 | Artal International Management S.A. | 10% owner | 85,891 | $1.1M | 0.21% | Corporate |
| 3 | Invus Global Management, LLC | 10% owner | 68,602 | $886K | 0.16% | Corporate |
| 4 | Invus Public Equities Advisors, LLC | 10% owner | 63,176 | $816K | 0.15% | Corporate |
| 5 | Jonathan Violin | Director | 695 | $9K | <0.1% | 6054th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Crescent Biopharma; see each profile for the filing.